Anne Keogh mainly investigates Internal medicine, Transplantation, Surgery, Cardiology and Heart transplantation. As part of her studies on Internal medicine, she often connects relevant subjects like Endocrinology. Anne Keogh interconnects Incidence, Gastroenterology, Intensive care medicine, Bone mineral and Azathioprine in the investigation of issues within Transplantation.
Her Surgery research includes themes of Cancer and Bone disease, Osteoporosis. Her work deals with themes such as Coronary artery disease, Cholesterol, Survival rate and Urology, which intersect with Heart transplantation. Her research in the fields of Treprostinil overlaps with other disciplines such as Associated Pulmonary Arterial Hypertension.
Anne Keogh focuses on Internal medicine, Cardiology, Surgery, Transplantation and Heart transplantation. Her work in the fields of Internal medicine, such as Heart failure, Pulmonary hypertension, Hemodynamics and Ventricular assist device, overlaps with other areas such as In patient. Her study on Cardiomyopathy, Carvedilol, Vascular resistance and Ejection fraction is often connected to Continuous flow as part of broader study in Cardiology.
Her work carried out in the field of Cardiomyopathy brings together such families of science as Genetics and Dilated cardiomyopathy. She has included themes like Immunosuppression and Urology in her Transplantation study. Her work focuses on many connections between Heart transplantation and other disciplines, such as Azathioprine, that overlap with her field of interest in Prednisolone.
Anne Keogh mainly investigates Internal medicine, Cardiology, Pulmonary hypertension, Heart transplantation and Transplantation. Anne Keogh focuses mostly in the field of Internal medicine, narrowing it down to matters related to Surgery and, in some cases, Obesity. Anne Keogh has researched Cardiology in several fields, including Lung transplantation, Interquartile range and Sildenafil.
Her Pulmonary hypertension research incorporates themes from Disease management, Disease, Pulmonary artery, Combination therapy and Hemodynamics. Her research in Heart transplantation tackles topics such as Donation which are related to areas like Machine perfusion. Her research integrates issues of Immunosuppression, Cohort study and Cohort in her study of Transplantation.
Anne Keogh mostly deals with Internal medicine, Cardiology, Pulmonary hypertension, Dilated cardiomyopathy and Heart transplantation. Her study explores the link between Internal medicine and topics such as Surgery that cross with problems in Obesity. Her Cardiology research incorporates elements of Lung transplantation, Clinical endpoint and Confidence interval.
Her Pulmonary hypertension research includes elements of Idiopathic interstitial pneumonia, Framingham Risk Score, Disease and Prognostic models. The Dilated cardiomyopathy study combines topics in areas such as Genetics, Gene and Genetic testing. Her Heart transplantation study contributes to a more complete understanding of Heart failure.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bosentan therapy for pulmonary arterial hypertension.
Lewis J. Rubin;David B. Badesch;Robyn J. Barst;Nazzareno Galiè.
The New England Journal of Medicine (2002)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.
Gerald Simonneau;Robyn J. Barst;Nazzareno Galie;Robert Naeije.
American Journal of Respiratory and Critical Care Medicine (2002)
The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients
Maria Rosa Costanzo;Anne Dipchand;Randall Starling;Allen Anderson.
Journal of Heart and Lung Transplantation (2010)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani;Nazzareno Galiè;Friedrich Grimminger;Ekkehard Grünig.
The New England Journal of Medicine (2013)
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
Jon Kobashigawa;Leslie Miller;Dale Renlund;Robert Mentzer.
Updated Treatment Algorithm of Pulmonary Arterial Hypertension
Nazzareno Galiè;Paul A Corris;Adaani Frost;Reda E Girgis.
Journal of the American College of Cardiology (2013)
Ambrisentan Therapy for Pulmonary Arterial Hypertension
Nazzareno Galié;David Badesch;Ronald Oudiz;Gérald Simonneau.
Journal of the American College of Cardiology (2005)
Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years A Randomized Clinical Trial
Anne Keogh;Meroula Richardson;Peter Ruygrok;Phillip Spratt.
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): A randomized controlled trial
Victor F. Tapson;Fernando Torres;Fiona Kermeen;Anne M. Keogh.
Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation
Anne M. Keogh;David W. Baron;John B. Hickie.
American Journal of Cardiology (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: